<DOC>
	<DOCNO>NCT01755754</DOCNO>
	<brief_summary>A multi-center , open-label , randomize , two-period , crossover non-inferiority trial ass functionality female condom silicone elastomer vaginal ring .</brief_summary>
	<brief_title>A Trial Assess Functionality Female Condom With Silicone Elastomer Vaginal Ring</brief_title>
	<detailed_description>This open-label , randomize , 2-period , crossover non-inferiority trial , conduct 4.5 month two research center USA among 81 healthy , monogamous , heterosexual , sexually active couple assess functionality female lubricate , nitrile condom vaginal intercourse presence absence silicone elastomer placebo vaginal ring .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>1 . Mutually monogamous heterosexual couple ; current relationship ≥3 month ; give write informed consent ; 2 . Age ≥18 ≤45 year ( female ) ≥18 ≤55 year ( male ) time screen visit ; 3 . Healthy basis medical history ; 4 . Not risk pregnancy , i.e. , female surgically sterile , use IUD , use effective hormonal contraception , vasectomized partner . The use vaginal contraceptive ring allow ; 5 . Sexually active agree least 8 act penilevaginal intercourse use study condom 2 period 4 week ; 6 . Agree use female condom provide trial personnel time participation use male condom trial . Additional lubricant provide ; use nonstudy lubricant allow ; 7 . Agree use genital jewelry vaginal product , except menstrual absorption product ( e.g. , tampon ) study lubricant trial ; 8 . Available visit consent follow procedure schedule trial ; 9 . At low risk HIV infection . 1 . Males untreated erectile dysfunction ; 2 . Female positive pregnancy test ; 3 . Either partner allergic hypersensitive vaginal lubricant Astorlige ® 4 . Either partner willing refrain wear genital pierce jewelry duration study 5 . History selfreport recurrent recentlytreated ( within past 2 week ) sexually transmit infection ( e.g . gonorrhea , syphilis , chlamydia ) HIV ( + ) ; 6 . Consistently use male female condom protection sexually transmitted infection ; 7 . Either partner take topical oral medication treat urogenital condition enrollment , except medication male partner treat erectile dysfunction ( e.g. , tadalafil , sildenafil ) ; 8 . Either partner selfreported clinically diagnose urogenital condition ( e.g . itching , burning , irritation , etc . ) , opinion Investigator , could affect use study condom ability interpret trial data ; 9 . Females , base finding pelvic examination , suitable candidate wear vaginal ring ( anatomical condition , current vaginal infection , etc . ) 10 . Current participation study research involve drug , device product ; 11 . Any condition ( ) , opinion Investigator , might interfere adherence trial requirement evaluation trial objective .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>